Crinetics Pharmaceuticals (CRNX) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 992.08 Mn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 832.98 Mn |
| Jun 30, 2024 | 830.76 Mn |
| Mar 31, 2024 | 874.93 Mn |
| Dec 31, 2023 | 539.11 Mn |
| Sep 30, 2023 | 547.75 Mn |
| Jun 30, 2023 | 254.12 Mn |
| Mar 31, 2023 | 280.33 Mn |
| Dec 31, 2022 | 316.33 Mn |
| Sep 30, 2022 | 351.37 Mn |
| Jun 30, 2022 | 386.17 Mn |
| Mar 31, 2022 | 303.04 Mn |
| Dec 31, 2021 | 331.94 Mn |
| Sep 30, 2021 | 193.59 Mn |
| Jun 30, 2021 | 201.44 Mn |
| Mar 31, 2021 | 149.48 Mn |
| Dec 31, 2020 | 168.92 Mn |
| Sep 30, 2020 | 187.22 Mn |
| Jun 30, 2020 | 202.77 Mn |
| Mar 31, 2020 | 108.44 Mn |
| Dec 31, 2019 | 117.14 Mn |
| Sep 30, 2019 | 129.52 Mn |
| Jun 30, 2019 | 142.10 Mn |
| Mar 31, 2019 | 152.39 Mn |
| Dec 31, 2018 | 160.23 Mn |
| Sep 30, 2018 | 167.52 Mn |
| Jun 30, 2018 | -25.18 Mn |
| Mar 31, 2018 | -19.98 Mn |
| Dec 31, 2017 | -15.02 Mn |